107 related articles for article (PubMed ID: 3305186)
1. Clinical trial of etoposide and cisplatin as salvage therapy in advanced ovarian carcinoma.
Dottino PR; Goodman HM; Kredentser D; Rosenberg M; Cohen CJ
Gynecol Oncol; 1987 Jul; 27(3):350-6. PubMed ID: 3305186
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of VP-16-213 in advanced ovarian carcinoma.
Hillcoat BL; Campbell JJ; Pepperell R; Quinn MA; Bishop JF; Day A
Gynecol Oncol; 1985 Oct; 22(2):162-6. PubMed ID: 4054715
[TBL] [Abstract][Full Text] [Related]
3. Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancer.
Chambers SK; Chambers JT; Kohorn EI; Schwartz PE
Gynecol Oncol; 1987 Jun; 27(2):233-40. PubMed ID: 3570062
[TBL] [Abstract][Full Text] [Related]
4. [The value of etoposide (VP-16) in the therapy of refractory ovarian cancer].
Marth C; Pointner E; Zeimet AG; Abfalter E; Koza A; Windbichler G; Hetzel H; Dapunt O
Geburtshilfe Frauenheilkd; 1993 May; 53(5):303-7. PubMed ID: 8514100
[TBL] [Abstract][Full Text] [Related]
5. Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study.
Markman M; Blessing JA; Major F; Manetta A
Gynecol Oncol; 1993 Aug; 50(2):191-5. PubMed ID: 8375734
[TBL] [Abstract][Full Text] [Related]
6. Treatment for recurrent ovarian cancer. A report of 2 cases.
Maxwell AM; Jordaan JP
S Afr Med J; 1987 Feb; 71(3):180. PubMed ID: 3810370
[TBL] [Abstract][Full Text] [Related]
7. [Intraperitoneal administration of high doses of cisplatin in advanced ovarian carcinoma].
Ptácková B; Kopecný J; Zatocil P; Anton M
Cesk Gynekol; 1989 Mar; 54(2):106-9. PubMed ID: 2731237
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma.
Beddoe AM; Dottino PR; Cohen CJ
Mt Sinai J Med; 1993 Sep; 60(4):311-6. PubMed ID: 8232377
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
[TBL] [Abstract][Full Text] [Related]
11. 4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer.
Martoni A; Tomasi L; Farabegoli G; Fruet F; Pannuti F
Cancer Treat Rep; 1984 Nov; 68(11):1391-3. PubMed ID: 6594196
[TBL] [Abstract][Full Text] [Related]
12. Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
Rose PG; Blessing JA; Mayer AR; Homesley HD
J Clin Oncol; 1998 Feb; 16(2):405-10. PubMed ID: 9469322
[TBL] [Abstract][Full Text] [Related]
13. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
Alici S; Saip P; Eralp Y; Aydiner A; Topuz E
Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885
[TBL] [Abstract][Full Text] [Related]
14. [Effect, toxicity and tissue concentration in the clinical use of cis-diamminedichloroplatinum (II)].
Kodama S; Obata N; Hando T; Ikarashi T; Goto A; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):683-90. PubMed ID: 4039742
[TBL] [Abstract][Full Text] [Related]
15. [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer].
Sevelda P; Kurz C; Obermair A; Vavra N; Breitenecker G; Czerwenka K; Dittrich C; Salzer H
Wien Klin Wochenschr; 1993; 105(24):732-6. PubMed ID: 8116312
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.
Markman M; Reichman B; Hakes T; Rubin S; Jones W; Lewis JL; Barakat R; Curtin J; Almadrones L; Hoskins W
Gynecol Oncol; 1992 Dec; 47(3):353-7. PubMed ID: 1473749
[TBL] [Abstract][Full Text] [Related]
17. Etoposide (VP-16) plus cisplatin (DDP): a new active chemotherapeutic combination in patients with stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
J Surg Oncol; 1986 May; 32(1):43-5. PubMed ID: 3724190
[TBL] [Abstract][Full Text] [Related]
18. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
[TBL] [Abstract][Full Text] [Related]
19. Cis-platinum plus high-dose methotrexate. Toxicity and efficacy in ovarian carcinoma.
Talley R; Boutseleis J; Neidhart JA
Am J Clin Oncol; 1983 Jun; 6(3):369-74. PubMed ID: 6682623
[TBL] [Abstract][Full Text] [Related]
20. cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma.
Veronesi A; Zagonel V; Santarossa M; Tirelli U; Galligioni E; Trovo' MG; Tumolo S; Grigoletto E
Cancer Chemother Pharmacol; 1983; 11(1):35-7. PubMed ID: 6683999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
